Page 59 - 2019食藥署年報(英文版)

'JHVSF cc" HSPVQ QIPUP PG PGGJDJBM QBSUJDJQBOUT JO UIF 5BJXBO "4&"/ ESVH SFHVMBUPSZ GPSVN

1SPNPUJOH UIF EFWFMPQNFOU PG EPNFTUJD CJPUFDIOPMPHZ QIBSNBDFVUJDBM

JOEVTUSZ

TFDA plans to create contacts for long-term communication and information exchanges
with other country's drug regulatory authorities or industry associations through information
exchanges with representatives of various countries, sharing experiences and understanding
the needs of other countries, and to increase the opportunities for information exchanges and
international cooperation with other countries.
Through the researches in information such as RCEP Pharmaceutical Product Working

Group (PPWG), RCEP national drug inspection, status of pharmaceutical manufacturers,
regulations for entering the market, medical insurance business, understanding the latest
information on the regional policy of integration in drug regulation in Asia, TFDA assisted
domestic pharmaceutical industry to understand the Asian market, and to enhance the
cooperation opportunity with international pharmaceutical industry. In addition, we increased
the opportunity of further training for different drug regulatory authorities to enhance their
capability and knowledge in drug regulation, strengthen the mechanism of the regulatory
harmonization, and enhance the opportunity for international cooperation.
The 4-day 2018 Taiwan-ASEAN Drug Regulatory Forum organized 2 expert meetings, 3

workshops, 3 information exchange meetings and held 1 symposium, collecting information or

57